Global Veterinary Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2025

In this report, our team research the global Veterinary Diagnostics market by type, application, region and manufacturer 2014-2019 and forcast 2020-2025. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Veterinary Diagnostics in these regions, from 2012 to 2023 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Veterinary Diagnostics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
IDEXX Laboratories
Abaxis
Thermo Fisher Scientific
Heska
Zoetis
Bio-Rad Laboratories
IDvet
Shenzhen Mindray Bio-Medical Electronics
NEOGEN CORPORATION
QIAGEN
VCA
Virbac
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immunodiagnostics
Molecular Diagnostics
Clinical Chemistry
Hematology Analyzers
Diagnostic Imagining
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Veterinary Diagnostics for each application, including
Livestock
Companion Animals

If you have any special requirements, please let us know and we will offer you the report as you want.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Diagnostics Market, By Product

7.1.  Veterinary Diagnostics Market, By Product, 2020-2028

7.1.1.    Consumables, Reagents & Kits

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Instruments & Devices

7.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Veterinary Diagnostics Market, By Species

8.1.  Veterinary Diagnostics Market, By Species, 2020-2028

8.1.1.    Bovine

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Camelid

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Canine and Feline

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Caprine

8.1.4.1.        Market Revenue and Forecast (2016-2028)

8.1.5.    Equine

8.1.5.1.        Market Revenue and Forecast (2016-2028)

8.1.6.    Ovine

8.1.6.1.        Market Revenue and Forecast (2016-2028)

8.1.7.    Porcine

8.1.7.1.        Market Revenue and Forecast (2016-2028)

8.1.8.    Avian

8.1.8.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Veterinary Diagnostics Market, By Testing Category

9.1.  Veterinary Diagnostics Market, By Testing Category, 2020-2028

9.1.1.    Analytical Services

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Diagnostic Imaging

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Bacteriology

9.1.3.1.        Market Revenue and Forecast (2016-2028)

9.1.4.    Pathology

9.1.4.1.        Market Revenue and Forecast (2016-2028)

9.1.5.    Molecular Diagnostics

9.1.5.1.        Market Revenue and Forecast (2016-2028)

9.1.6.    Immunoassays

9.1.6.1.        Market Revenue and Forecast (2016-2028)

9.1.7.    Parasitology

9.1.7.1.        Market Revenue and Forecast (2016-2028)

9.1.8.    Serology

9.1.8.1.        Market Revenue and Forecast (2016-2028)

9.1.9.    Virology

9.1.9.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Veterinary Diagnostics Market, By Disease Type

10.1.        Veterinary Diagnostics Market, By Disease Type, 2020-2028

10.1.1.  Infectious Diseases

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Non-infectious Diseases

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  Hereditary, Congenital, and Acquired Diseases

10.1.3.1.      Market Revenue and Forecast (2016-2028)

10.1.4.  General Ailments

10.1.4.1.      Market Revenue and Forecast (2016-2028)

10.1.5.  Structural and Functional Diseases

10.1.5.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Veterinary Diagnostics Market, By End-Use

11.1.        Veterinary Diagnostics Market, By End-Use, 2020-2028

11.1.1.  Laboratories

11.1.1.1.      Market Revenue and Forecast (2016-2028)

11.1.2.  Veterinary Hospitals and Clinics

11.1.2.1.      Market Revenue and Forecast (2016-2028)

11.1.3.  Point-Of-Care/In-House Testing

11.1.3.1.      Market Revenue and Forecast (2016-2028)

11.1.4.  Research Institutes and Universities

11.1.4.1.      Market Revenue and Forecast (2016-2028)

Chapter 12.      Global Veterinary Diagnostics  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product (2016-2028)

12.1.2.  Market Revenue and Forecast, By Species (2016-2028)

12.1.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.1.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.1.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.1.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.1.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.1.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.1.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.1.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.1.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.1.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.1.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product (2016-2028)

12.2.2.  Market Revenue and Forecast, By Species (2016-2028)

12.2.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.8.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.8.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.8.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.8.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.9.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.9.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.9.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.9.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product (2016-2028)

12.3.2.  Market Revenue and Forecast, By Species (2016-2028)

12.3.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.8.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.8.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.8.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.8.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.9.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.9.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.9.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.9.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product (2016-2028)

12.4.2.  Market Revenue and Forecast, By Species (2016-2028)

12.4.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.8.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.8.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.8.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.8.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.9.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.9.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.9.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.9.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product (2016-2028)

12.5.2.  Market Revenue and Forecast, By Species (2016-2028)

12.5.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.5.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.5.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.5.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.5.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.5.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.5.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.5.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.5.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.5.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.5.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

Chapter 13.  Company Profiles

13.1.              Abaxis, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Idexx Laboratories, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Heska Corporation

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Neogen Corp

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Merck

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Thermo Fisher Scientific, Inc

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Qiagen N.V.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Virbac Corp

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Zoetis, Inc.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           IDVet

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Agrolabo SPA

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           Im3 Inc.

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

13.13.           VCA Antech

13.13.1.               Company Overview

13.13.2.               Product Offerings

13.13.3.               Financial Performance

13.13.4.               Recent Initiatives

13.14.           Henry Schein, Inc.

13.14.1.               Company Overview

13.14.2.               Product Offerings

13.14.3.               Financial Performance

13.14.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers